• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Stocks That Hit 52-Week Lows On Wednesday

    6/14/23 1:13:07 PM ET
    $AKU
    $AY
    $BENF
    $BIOC
    Medical Specialities
    Health Care
    Electric Utilities: Central
    Utilities
    Get the next $AKU alert in real time by email

     

    On Wednesday, 33 stocks hit new 52-week lows.

    Interesting Facts About Today's 52-Week Lows:

    • The largest company by market cap to set a new 52-week low was UnitedHealth Group (NYSE:UNH).
    • Biocept (NASDAQ:BIOC) was the smallest, in terms of market cap, to set a new 52-week low.
    • Tenon Medical (NASDAQ:TNON) shares traded down 51.96% to reach its 52-week low, making it the biggest loser.
    • Camber Energy (AMEX:CEI) shares actually gained 0.16%, rebounding after it reached its 52-week low.

    The stocks that set new 52-week lows on Wednesday:

    • UnitedHealth Group (NYSE:UNH) stock dropped to a yearly low on Wednesday of $445.83. Shares traded down 7.25%.
    • Atlantica Sustainable (NASDAQ:AY) stock drifted down 1.08% on Wednesday morning to hit a new 52-week low of $23.70.
    • Beneficient (NASDAQ:BENF) stock set a new 52-week low of $5.21 on Wednesday, moving down 7.19%.
    • PolyMet Mining (AMEX:PLM) shares hit a yearly low of $0.82. The stock was up 0.22% on the session.
    • Intevac (NASDAQ:IVAC) stock drifted down 13.84% on Wednesday morning to hit a new 52-week low of $3.68.
    • Precision BioSciences (NASDAQ:DTIL) shares hit a yearly low of $0.66. The stock was down 3.52% on the session.
    • Mullen Automotive (NASDAQ:MULN) shares made a new 52-week low of $0.27 on Wednesday. The stock was down 12.88% for the day.
    • FLJ Group (NASDAQ:FLJ) shares hit a yearly low of $0.28. The stock was down 13.73% on the session.
    • Great Elm Capital (NASDAQ:GECC) shares made a new 52-week low of $7.55 on Wednesday. The stock was down 3.5% for the day.
    • Passage Bio (NASDAQ:PASG) shares set a new 52-week low of $0.93. The stock traded down 0.75%.
    • IO Biotech (NASDAQ:IOBT) shares hit a yearly low of $1.58. The stock was down 19.66% on the session.
    • Upexi (NASDAQ:UPXI) shares set a new yearly low of $2.04 this morning. The stock was down 6.74% on the session.
    • Trio Petroleum (AMEX:TPET) stock hit $1.30 on Wednesday morning, setting a new 52-week low for a change of down 2.96%.
    • Akumin (NASDAQ:AKU) shares reached a new 52-week low of $0.33 on Wednesday morning, moving up 2.19%.
    • Castellum (AMEX:CTM) shares fell to $0.56 on Wednesday, setting a new 52-week low with a shift of down 4.72%.
    • Camber Energy (AMEX:CEI) stock hit a new 52-week low of $1.00. The stock was up 0.16% on the session.
    • iClick Interactive Asia (NASDAQ:ICLK) stock hit $2.05 on Wednesday morning, setting a new 52-week low for a change of down 4.66%.
    • Cineverse (NASDAQ:CNVS) stock hit $2.20 on Wednesday morning, setting a new 52-week low for a change of down 35.53%.
    • SMX (Security Matters) (NASDAQ:SMX) shares fell to $0.62 on Wednesday, setting a new 52-week low with a shift of down 17.84%.
    • Bluejay Diagnostics (NASDAQ:BJDX) stock hit a yearly low of $0.19. The stock was down 4.55% for the day.
    • OceanPal (NASDAQ:OP) shares reached a new 52-week low of $2.53 on Wednesday morning, moving down 7.66%.
    • TC BioPharm (Holdings) (NASDAQ:TCBP) shares set a new yearly low of $0.59 this morning. The stock was up 1.37% on the session.
    • INVO Bioscience (NASDAQ:INVO) stock hit a yearly low of $0.15. The stock was down 5.27% for the day.
    • Biocept (NASDAQ:BIOC) stock set a new 52-week low of $1.64 on Wednesday, moving down 2.58%.

    Be sure to stay with Benzinga for further updates and market-moving news. And if you want to be among the first to know about the 52-week highs and lows for the day, check out Benzinga Pro. Users receive a daily alert listing stocks trading near 52-week highs and lows each morning. Click here to learn more.

    Get the next $AKU alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AKU
    $AY
    $BENF
    $BIOC

    CompanyDatePrice TargetRatingAnalyst
    Cineverse Corp.
    $CNVS
    2/19/2026$12.00Speculative Buy → Buy
    The Benchmark Company
    Passage Bio Inc.
    $PASG
    2/10/2026$21.00Buy
    Chardan Capital Markets
    IO Biotech Inc.
    $IOBT
    1/26/2026$0.50Overweight → Neutral
    Piper Sandler
    IO Biotech Inc.
    $IOBT
    1/8/2026$0.36Equal-Weight → Underweight
    Morgan Stanley
    UnitedHealth Group Incorporated
    $UNH
    10/29/2025$333.00Buy → Hold
    Deutsche Bank
    UnitedHealth Group Incorporated
    $UNH
    10/14/2025$406.00Buy
    Goldman
    IO Biotech Inc.
    $IOBT
    9/30/2025$0.39Overweight → Equal-Weight
    Morgan Stanley
    IO Biotech Inc.
    $IOBT
    9/30/2025Buy → Hold
    TD Cowen
    More analyst ratings

    $AKU
    $AY
    $BENF
    $BIOC
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Pres Tech/Chief Product Off Huidor Mark Antonio bought $75,000 worth of shares (37,500 units at $2.00), increasing direct ownership by 25% to 190,061 units (SEC Form 4)

    4 - Cineverse Corp. (0001173204) (Issuer)

    2/17/26 9:57:19 PM ET
    $CNVS
    Consumer Electronics/Video Chains
    Consumer Discretionary

    CFO Lindsey Mark Wayne bought $70,000 worth of shares (35,000 units at $2.00), increasing direct ownership by 29% to 154,168 units (SEC Form 4)

    4 - Cineverse Corp. (0001173204) (Issuer)

    2/17/26 9:54:43 PM ET
    $CNVS
    Consumer Electronics/Video Chains
    Consumer Discretionary

    Chief Motion Pictures Officer Macias Yolanda sold $5,297 worth of shares (2,189 units at $2.42) and bought $60,000 worth of shares (30,000 units at $2.00), increasing direct ownership by 30% to 121,760 units (SEC Form 4)

    4 - Cineverse Corp. (0001173204) (Issuer)

    2/17/26 9:54:04 PM ET
    $CNVS
    Consumer Electronics/Video Chains
    Consumer Discretionary

    $AKU
    $AY
    $BENF
    $BIOC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Upexi to Participate in Upcoming March Investor Conferences

    TAMPA, Fla., March 03, 2026 (GLOBE NEWSWIRE) -- Upexi, Inc. (NASDAQ:UPXI) ("Upexi" or the "Company"), a leading Solana-focused digital asset treasury company and consumer brands owner, today announced that management will participate in the following March 2026 investor conferences. Full details for each conference can be found below. Webull Digital Asset Treasury Crypto WebinarDate: March 12, 2026, 1:40 PM ETSpeaker: Brian Rudick, Chief Strategy OfficerType: Virtual PresentationWebcast: https://ir.upexi.com/news-events/ir-calendar 38th Annual ROTH ConferenceDate: March 22-24, 2026Location: The Ritz-Carlton Laguna Niguel, Dana Point, CAAttendees: Allan Marshall, Chief Executive Officer;

    3/3/26 8:00:00 AM ET
    $UPXI
    Medicinal Chemicals and Botanical Products
    Health Care

    Passage Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Recent Business Highlights

    Enrolled first three FTD-GRN patients in Cohort 3 of ongoing upliFT-D study Treated first FTD-C9orf72 patient with Dose 2 PBFT02 in Cohort 4 of upliFT-D study On track to report updated interim safety and biomarker data from upliFT-D and obtain regulatory feedback on FTD-GRN registrational trial design in 1H 2026 Advancing differentiated preclinical program for Huntington's with clinical candidate selection expected in 2H 2026 Cash runway through 1Q 2027 PHILADELPHIA, March 03, 2026 (GLOBE NEWSWIRE) -- Passage Bio, Inc. (NASDAQ:PASG), a clinical stage genetic medicines company focused on improving the lives of patients with neurodegenerative diseases, today reported financial results

    3/3/26 7:00:00 AM ET
    $PASG
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Great Elm Capital Corp. Announces Fourth Quarter and Full Year 2025 Financial Results and New Executive Chairman of Board

    Company to Host Conference Call and Webcast at 8:30 AM ET on March 3, 2026 Jason Reese Appointed as Executive Chairman of the Board of Directors, Succeeding Matthew Drapkin and Fortifying the Board's Management Oversight Mr. Drapkin Continues to Serve as Vice Chairman of Great Elm Group, Inc. - Remaining Engaged with GECC and Great Elm Capital Management, LLC, its Investment Adviser Platform Strengthened with Seasoned Credit Investor Chris Croteau Hired as Head of Research GECC's Investment Adviser Waives All Accrued Incentive Fees as of December 31, 2025, Equating to Approximately $2.3 Million, or $0.16 Per Share, and 1Q 2026 Incentive Fees Waived as Well GAAP NAV of $8.07 Per Share a

    3/2/26 5:47:04 PM ET
    $GECC
    $GEG
    Finance: Consumer Services
    Finance
    Computer Software: Prepackaged Software
    Technology

    $AKU
    $AY
    $BENF
    $BIOC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Accounting Officer Roos Thomas E covered exercise/tax liability with 152 shares and was granted 2,436 shares, increasing direct ownership by 8% to 31,284 units (SEC Form 4)

    4 - UNITEDHEALTH GROUP INC (0000731766) (Issuer)

    2/25/26 4:11:27 PM ET
    $UNH
    Medical Specialities
    Health Care

    EVP & Chief Legal Officer Zaetta Christopher R covered exercise/tax liability with 129 shares and was granted 7,084 shares, increasing direct ownership by 72% to 16,627 units (SEC Form 4)

    4 - UNITEDHEALTH GROUP INC (0000731766) (Issuer)

    2/25/26 4:10:26 PM ET
    $UNH
    Medical Specialities
    Health Care

    Chief Executive Officer, UHC Noel Timothy John covered exercise/tax liability with 123 shares and was granted 8,855 shares, increasing direct ownership by 100% to 17,472 units (SEC Form 4)

    4 - UNITEDHEALTH GROUP INC (0000731766) (Issuer)

    2/25/26 4:09:31 PM ET
    $UNH
    Medical Specialities
    Health Care

    $AKU
    $AY
    $BENF
    $BIOC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Cineverse upgraded by The Benchmark Company with a new price target

    The Benchmark Company upgraded Cineverse from Speculative Buy to Buy and set a new price target of $12.00

    2/19/26 7:46:51 AM ET
    $CNVS
    Consumer Electronics/Video Chains
    Consumer Discretionary

    Chardan Capital Markets resumed coverage on Passage BIO with a new price target

    Chardan Capital Markets resumed coverage of Passage BIO with a rating of Buy and set a new price target of $21.00

    2/10/26 6:56:48 AM ET
    $PASG
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    IO Biotech downgraded by Piper Sandler with a new price target

    Piper Sandler downgraded IO Biotech from Overweight to Neutral and set a new price target of $0.50

    1/26/26 10:01:23 AM ET
    $IOBT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AKU
    $AY
    $BENF
    $BIOC
    SEC Filings

    View All

    SEC Form 10-K filed by Passage Bio Inc.

    10-K - Passage BIO, Inc. (0001787297) (Filer)

    3/3/26 7:15:58 AM ET
    $PASG
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Passage Bio Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Passage BIO, Inc. (0001787297) (Filer)

    3/3/26 7:00:21 AM ET
    $PASG
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Great Elm Capital Corp. filed SEC Form 8-K: Results of Operations and Financial Condition, Leadership Update, Financial Statements and Exhibits

    8-K - Great Elm Capital Corp. (0001675033) (Filer)

    3/2/26 5:10:04 PM ET
    $GECC
    Finance: Consumer Services
    Finance

    $AKU
    $AY
    $BENF
    $BIOC
    Leadership Updates

    Live Leadership Updates

    View All

    Cineverse and GameStop Invite Fans to 'Return to Silent Hill' with Innovative Partnership featuring Mysterious Messages, Exclusive Rewards, In-Store Media & More

    Return to Silent Hill Hits Theaters Nationwide on January 23 – Buy Tickets Now LOS ANGELES and GRAPEVINE, Texas, Jan. 14, 2026 /PRNewswire/ -- Cineverse (NASDAQ:CNVS), a next generation entertainment studio, and GameStop Corp. (NYSE:GME), are pulling out all the stops in anticipation of the January 23 wide theatrical release of Return to Silent Hill (returntosilenthillmovie.com).  The two companies are collaborating on an immersive marketing campaign for the new film, based on the visionary video game, SILENT HILL 2. Since January 7, fans who visit a participating GameStop ca

    1/14/26 3:02:00 PM ET
    $CNVS
    $GME
    Consumer Electronics/Video Chains
    Consumer Discretionary
    Electronics Distribution

    Beneficient Appoints Peter T. Cangany Jr. as Chairman of the Board

    DALLAS, Dec. 17, 2025 (GLOBE NEWSWIRE) -- Beneficient (NASDAQ:BENF) ("Ben" or the "Company"), a technology-enabled platform providing exit opportunities and primary capital solutions and related trust and custody services to holders of alternative assets, today announced that its Board of Directors (the "Board") has appointed Peter T. Cangany Jr. as Chairman of the Board, effective December 15, 2025. Mr. Cangany has served as a director of Beneficient and as Chairman of its independent Audit Committee since 2019. He brings decades of leadership experience in financial reporting, accounting, and corporate governance within the financial services industry. Mr. Cangany retired as a partner

    12/17/25 7:30:00 AM ET
    $BENF
    Finance: Consumer Services
    Finance

    Upexi Welcomes Jon Najarian to the Upexi Advisory Committee

    TAMPA, Fla., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Upexi, Inc. (NASDAQ:UPXI), a brand owner specializing in the development, manufacturing, and distribution of consumer products with diversification into the cryptocurrency space, today announced the addition of Jon Najarian (Twitter: @jonnajarian) to the Upexi Advisory Committee, joining Arthur Hayes and S◎L Big Brain as founding Upexi Advisory Committee members. Jon Najarian is a highly influential figure in the world of finance, renowned for his deep expertise in options trading and market strategy. A former professional football player, Jon co-founded options trading firm Mercury Trading and later launched financial education company Marke

    10/23/25 8:00:00 AM ET
    $UPXI
    Medicinal Chemicals and Botanical Products
    Health Care

    $AKU
    $AY
    $BENF
    $BIOC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Great Elm Capital Corp.

    SC 13D/A - Great Elm Capital Corp. (0001675033) (Subject)

    12/13/24 6:47:34 PM ET
    $GECC
    Finance: Consumer Services
    Finance

    Amendment: SEC Form SC 13D/A filed by Atlantica Sustainable Infrastructure plc

    SC 13D/A - Atlantica Sustainable Infrastructure plc (0001601072) (Subject)

    12/12/24 12:30:42 PM ET
    $AY
    Electric Utilities: Central
    Utilities

    SEC Form SC 13G filed by Great Elm Capital Corp.

    SC 13G - Great Elm Capital Corp. (0001675033) (Subject)

    12/12/24 8:44:54 AM ET
    $GECC
    Finance: Consumer Services
    Finance

    $AKU
    $AY
    $BENF
    $BIOC
    Financials

    Live finance-specific insights

    View All

    Great Elm Capital Corp. Announces Fourth Quarter and Full Year 2025 Financial Results and New Executive Chairman of Board

    Company to Host Conference Call and Webcast at 8:30 AM ET on March 3, 2026 Jason Reese Appointed as Executive Chairman of the Board of Directors, Succeeding Matthew Drapkin and Fortifying the Board's Management Oversight Mr. Drapkin Continues to Serve as Vice Chairman of Great Elm Group, Inc. - Remaining Engaged with GECC and Great Elm Capital Management, LLC, its Investment Adviser Platform Strengthened with Seasoned Credit Investor Chris Croteau Hired as Head of Research GECC's Investment Adviser Waives All Accrued Incentive Fees as of December 31, 2025, Equating to Approximately $2.3 Million, or $0.16 Per Share, and 1Q 2026 Incentive Fees Waived as Well GAAP NAV of $8.07 Per Share a

    3/2/26 5:47:04 PM ET
    $GECC
    $GEG
    Finance: Consumer Services
    Finance
    Computer Software: Prepackaged Software
    Technology

    Great Elm Capital Corp. ("GECC") Schedules Fourth Quarter and Full Year 2025 Earnings Release and Conference Call

    PALM BEACH GARDENS, Fla., Feb. 27, 2026 (GLOBE NEWSWIRE) -- Great Elm Capital Corp. (the "Company" or "GECC") (NASDAQ:GECC), a business development company, today announced that it will release its financial results for the fourth quarter and full year ended December 31, 2025, after the close of market trading on Monday, March 2, 2026. The results will be discussed in a conference call on Tuesday, March 3, 2026, at 8:30 a.m. ET. Date/Time:Tuesday, March 3, 2026 – 8:30 a.m. ET   Participant Dial-In Numbers: (United States):(877) 407-0789(International):(201) 689-8562   To access the call, please dial-in approximately five minutes before the start time and, when asked, provide the operator w

    2/27/26 4:22:51 PM ET
    $GECC
    Finance: Consumer Services
    Finance

    UnitedHealth Group Board Authorizes Payment of Quarterly Dividend

    The UnitedHealth Group (NYSE:UNH) board of directors has authorized payment of a cash dividend of $2.21 per share, to be paid on March 17, 2026, to all shareholders of record of UNH common stock as of the close of business March 9, 2026. About UnitedHealth Group UnitedHealth Group (NYSE:UNH) is a health care and well-being company with a mission to help people live healthier lives and help make the health system work better for everyone through two distinct and complementary businesses. Optum delivers care aided by technology and data, empowering people, partners and providers with the guidance and tools they need to achieve better health. UnitedHealthcare offers a full range of health

    2/25/26 6:50:00 AM ET
    $UNH
    Medical Specialities
    Health Care